Delivery Order 36C24223D0044-36C24224N0284

Award Date 2/13/24
Potential Completion Date 2/12/25
Potential Value $120K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
New York, NY 10010, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Cytopath Biopsy Lab Inc., doing business as Cblpath, was awarded a $168,000 firm fixed price delivery order for ThyroSeq testing services under the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8 blanket purchase agreement. Cblpath will provide cancer diagnostic testing to help evaluate patients for thyroid cancer at the Port Chester, New York facility through January 2025. The testing supports the VA's efforts to accurately diagnose and...
Cytopath Biopsy Lab Inc., doing business as Cblpath, has been awarded a $94,000 firm fixed price delivery order contract to provide ThyroSeq cancer tests to the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8. Under this contract, Cblpath will deliver 60 ThyroSeq cancer tests per month for 12 months to support medical services for veterans in the Port Chester, New York area. No set-aside designation was applied to this award made using the...
This $64,400.00 firm fixed price delivery order was awarded to Cytopath Biopsy Lab Inc. (doing business as Cblpath) by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 2. The order is for cytopathology and ThyroSequence genetic testing services to support the VA's cancer screening and diagnosis programs. Cblpath is a specialized anatomic pathology and molecular diagnostics laboratory that has previously provided ThyroSequence testing to the VA and Department of Defense...
Cytopath Biopsy Lab Inc., doing business as Cblpath, has been awarded a $12,000 firm fixed price delivery order contract for cytopathology and ThyroSeq testing services. The contract is associated with the Department of Veterans Affairs Veterans Health Administration's Veterans Integrated Service Network 4 and has a period of performance through May 31, 2023. Under this contract, Cblpath will provide cytopathology laboratory testing and molecular diagnostic testing for thyroid cancer to...
<p>The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 2 (VA - VHA) awarded a $360,000 firm fixed price delivery order contract to Cytopath Biopsy Lab Inc., doing business as Cblpath, for Thyrosequence Testing Services. The contract has a place of performance in New York, New York and runs from February 13, 2023 through February 12, 2028.</p>
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 2 awarded a $37,985 firm fixed price delivery order contract to Cytopath Biopsy Lab Inc., doing business as Cblpath, for cytopathology and thyrosequence testing services. The contract has a period of performance through December 9, 2022 to provide diagnostic pathology testing support for VISN 2, which oversees VA medical centers in New York and surrounding areas. No set-aside provisions were...
Cytopath Biopsy Lab Inc., doing business as Cblpath, was awarded a $287,225 firm fixed price blanket purchase agreement call contract by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 1. The contract is for thyroid sequencing testing services to support VHA's healthcare programs. Cblpath will provide sequencing and analysis of thyroid samples to the VA medical center in Port Chester, New York. No set-aside designation was used for this...
This is a federal contract award to Cytopath Biopsy Lab Inc., doing business as Cblpath, to provide ThyroSequence Testing Services to the Veterans Integrated Service Network 2 (VISN 2) of the Department of Veterans Affairs (VA). The contract is a Delivery Order with a Firm Fixed Price pricing type, with a total ceiling value of $120,000.00 and a period of performance through February 12, 2028. This award is not set aside and is likely part of a larger Indefinite Delivery/Indefinite Quantity...
Cytopath Biopsy Lab Inc., doing business as Cblpath, has been awarded a firm fixed price contract valued at seventy-two thousand dollars by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 19. The contract calls for Cblpath to provide molecular thyroid mutation reference testing services in support of the agency's research programs for one year under a Blanket Purchase Agreement call order. Place of performance will be in Port Chester, New...
This federal contract award, valued at $16,415.00, is a Delivery Order placed under an Indefinite Delivery/Indefinite Quantity (IDIQ) contract by the Veterans Integrated Service Network 2 (VISN 2), a division of the U.S. Department of Veterans Affairs (VA). The contract is for Cytopathology and ThyroSequence Testing Services to be provided by the prime contractor, Cytopath Biopsy Lab Inc., doing business as Cblpath. Cblpath is a for-profit organization that specializes in cancer screening and...
  • 36C24223D0044
    Indefinite Delivery Contract
  • 36C24223D0044-36C24224N0284
    Delivery Order

Cytopath Biopsy Lab Inc., doing business as Cblpath, has been awarded a $120,000 firm fixed price delivery order for Thyrosequence Testing Services from the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 2. The delivery order was issued on February 13, 2024 with a completion date of February 12, 2025. It is being performed in New York, NY under an existing Indefinite Delivery/Indefinite Quantity contract vehicle between Cblpath and VISN 2 for the provision of Thyrosequence molecular diagnostic testing services to support the cancer screening and diagnosis programs within the regional VA healthcare network through 2025. No set-aside designation was used for this particular award.

Generated 1/26/24, 9:54 AM